Diagnostic and Therapeutic Benefits of BioMark’s Cancer Marker Featured in Two Poster Presentations at the Canadian Cancer Research Conference
Vancouver, British Columbia–(Newsfile Corp. – November 8, 2021) – BioMark Diagnostics Inc. (CSE: BUX) (FSE:…